Clinical trial
Exemestane With or Without Bicalutamide in Treating Patients With Stage IV…
NCT00031889 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00031889 |
|---|---|
| Title | Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer |
| Official title | A Randomized Phase II Trial of Exemestane With and Without Bicalutamide as Second Line Therapy After Failure of Androgen Suppression in Advanced Prostate Cancer |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Exemestane, Exemestane+bicalutamide |
| Enrollment | 5 |
| Start date | Aug 1, 2001 |
| Primary completion | Jun 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Jul 1, 2003 |
| Last update posted | May 15, 2012 |
| Countries | Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: